Washington, DC. - The Food and Drug Law Institute (FDLI) welcomes four new exemplary leaders to its board of directors: Jennifer L. Bragg, Partner, Skadden, Arps, Slate, Meagher & Flom L...read more

We invite you to share your ideas for topics and speakers for the 2016 Annual Conference.read more

Get specific how-to guidance and a thorough understanding of complex issues offered at only $45 each for members read more

Latest Policy Forum Now Available

Posted on November 2015 by

The authors make the case against regulatory efforts to rein in drug prices.read more

Train Your Staff With FDLI

Posted on November 2015 by

Let FDLI train your staff with introductory courses. You select the topic and FDLI provides the training.read more

The law student writing competition is open for submissions.  Prizes total $10,000.read more

FDLI periodically seeks input from members to help us enhance our offerings. Please spend a minute and complete our brief survey. read more

GRAS, or generally recognized as safe, is an exemption that allows ingredients that are considered to be GRAS for their intended use to be exempt from FDA premarket review when added to food. The G...read more

E-cigarettes are an increasingly hot topic in the tobacco world, especially after the release of FDA’s proposed deeming regulations in April of 2014. The proposed regulations aim to bring pre...read more

FDLI Names New President and Chief Executive Officer

Posted on May 2014 by Michael Levin‐Epstein

FDLI Names New President and Chief Executive Officer Amy Comstock Rick to lead organization effective August 25th The Food and Drug Law Institute (FDLI) announces the selection of Amy Comstock Ric...read more